Resistance-exercise volume is a determinant of training outcomes. How-43 ever not all individuals respond in a dose-dependent fashion. In this study, 34 44 healthy individuals (males n = 16, age 23.6 (4.1) years; females n = 18, 22.0 (1.3) 45 years) performed moderate-(3 sets per exercise, MOD) and low-volume (1 set, 46 LOW) resistance training contralateral fashion for 12 weeks (2-3 sessions×week −1 ) 47 enabling intra-individual comparisons of effects of training modalities. Muscle 48 cross-sectional area (CSA) and muscle strength was assessed at weeks 0 and 12, 49 along with biopsy sampling (m. Vastus lateralis). Muscle biopsies were also 50 sampled before and one hour after the fifth session (Week 2). MOD resulted 51 in larger increases in muscle CSA (5.2 (3.8)% versus 3.7 (3.7)%, P <0.001) and 52 strength (3.4-7.7% difference, all P < 0.05). In muscle, this coincided with greater 53 reductions in type IIX fibres from week 0 to week 12 (MOD, -4.6 vs. LOW -54 3.2%-point), greater post-exercise (Week 2) phosphorylation of mTOR (12%), S6-55 kinase 1 (19%) and ribosomal protein S6 (28%, Week 2), greater rested-state total 56 RNA (8.8%, Week 2) and greater exercise-induced elevation of c-Myc mRNA 57 expression (25%, Week 2; all P < 0.05). Fifteen participants displayed robust 58 benefits of MOD on muscle hypertrophy. This was associated with greater ac-59 cumulation of total RNA at Week 2 in MOD vs. LOW as every 1% difference 60 increased the odds of MOD benefit by 5.4% (P = 0.010). In conclusion, MOD 61 led to on average greater adaptations to resistance training and dose-dependent 62 hypertrophy was associated with volume-dependent regulation of total RNA at 63 week 2. This suggests that ribosomal biogenesis regulates the dose-response re-64 lationship between training volume and muscle hypertrophy.
Introduction 67
In humans, the biological adaptation to resistance training varies with exercise-training Maximal strength was assessed as one repetition-maximum (1RM) in leg-press and 197 knee-extension. The test session for each exercise started with specific warm-up con-198 sisting of ten, six and three repetitions at 50, 75 and 85% of the anticipated maximum. 199 Thereafter, 1RM was found by increasing the resistance progressively until the weight 200 could not be lifted through the full range of motion. For each exercise, the highest load 201 successfully attempted was defined as 1RM. Each participant was given four to six at-202 tempts. Prior to the intervention, 1RM was tested twice separated by at least four days 203 with the maximum from the two sessions recorded as baseline 1RM. A subset of the par-204 ticipants (n=18) performed strength assessment during the course of the study (at week 5 205 and 9). For the remaining participants, ordinary training sessions were prioritized when 206 participants missed out on training or testing due to e.g. illness or scheduling difficulties.
207
Muscle cross-sectional area (CSA) and body composition. 208 Knee-extensor muscle CSA (vastus lateralis, medialis, intermedius and rectus femoris) 209 was determined before and after the training intervention using magnetic resonance imag-210 ing (MRI) in accordance with manufacturer's protocol (S-Scan, Esaote Europe B.V., Maas-211 tricht, Netherlands). Images were analyzed in a blinded fashion by the same investigator, 212 using OsiriX (v.5.6, Pixmeo Sarl, Bernex, Switzerland) . For each participant, CSA was de-213 termined at the same distance from the knee-joint pre-and post-intervention (mid-thigh), 214 using at least four consecutive images (5 mm thickness, 10 mm separation; see Figure 2A 215 for representative images). Body composition was determined before and after the inter-216 vention using dual-energy X-ray absorptiometry (DXA) (Lunar Prodigy, GE healthcare), 217 in accordance with standard protocol. Prior to MRI and DXA measurements, participants 218 were asked to stay fasted for 2 h and to refrain from vigorous physical activity for 48 h.
Hormonal measurements 220
Hormone analyses were performed on blood samples collected at five time points: along-221 side muscle biopsies (Figure 1 , four sampling events) and 10 minutes after completion 222 of the fifth training session. Samples were drawn from an antecubital vein into serum-223 separating tubes and kept at room temperature for 30 min before centrifugation (1500 224 g, 10 min). Serum was immediately aliquoted and stored at -80 ○ C until further process- 225 ing. Serum concentrations of total testosterone, cortisol, growth hormone and insulin-like 226 growth-factor 1 (IGF-1) were measured on an Immulite 1000 analyzer, using kits from 227 the Immulite Immunoassay System menu (Siemens Medical Solutions Diagnostics, NY, 228 USA), performed according to manufacturer's protocols. Serum Vitamin D (S-25-OH-229 D) levels were measured in samples collected before and after the intervention using a 230 electrochemiluminescence immunoassay (Roche Cobas Vitamin D total assay, Roche Di-231 agnostics GmbH., Mannheim, Germany) using automated instrumentation (Roche Cobas 232 6000's module e601, Roche Diagnostics GmbH., Mannheim, Germany).
233
Muscle tissue sampling and processing.
234
Muscle biopsies were obtained bilaterally from m. vastus lateralis under local anesthesia 235 (Xylocaine, 10 mg × ml −1 with adrenaline 5 µg × ml −1 , AstraZeneca AS, Oslo, Norge) using 236 a 12-gauge needle (Universal-plus, Medax, San Possidonio, Italy) operated with a spring 237 loaded biopsy instrument (Bard Magnum, Bard, Rud, Norway). For each participant, 238 resting samples were collected at the same time of day at all time-points and all sampling 239 was done in the morning after a standardised breakfast. Participants were instructed to 240 standardise meals during the last 24 h leading up to the sampling and to refrain from 241 strenous physical activity the last 48 h.
242
Samples were obtained within 10 minutes from both legs at all time-points. The first 243 biopsy was sampled 1/3 of the distance from the patella to anterior superior iliac spine, was quickly dissected free of blood and visible connective tissue in ice-cold sterile saline 246 solution (0.9% NaCl). Samples for immunohistochemistry (∼ 15 mg) were transferred to a 247 4% formalin solution for fixation 24-72 h, before further preparation. Samples for protein 248 and RNA analyses (∼ 60 mg) were blotted dry, snap-frozen using −80 ○ C isopentane and 249 stored at −80 ○ C until further analyses. (for representative image, see Figure 5B ). Fibres identified as hybrid fibers were analyzed 260 as 0.5 × Type IIA and 0.5 × Type IIX.
261
Protein extraction and immunoblotting buffer (Bio-Rad Laboratories AB, Oslo Norway) containing 2-Mercaptoethanol. Samples 271 were heated to 95 ○ C for 5 min and stored at -20 ○ C until further processing. During anal-272 yses, protein samples (20 µg of total protein) were separated at 300 V for 30 min using 273 4-20% gels (Criterion TGX, Bio-Rad), followed by wet transfer to PVDF membranes (0.2 274 µm Immun-Blot, Bio-Rad) at 300 mA for 3 h. Gel electrophoresis and protein transfer 275 were performed at 4 ○ C. Membranes were then stained using a reversible total protein West Femto Maximum Sensitivity Substrate, ThermoFischer Scientific), membranes were 286 incubated with hydrogen peroxide (15 min, 37 ○ C) to inactivate the horseradish peroxidase 287 (HRP), as described by Sennepin et al. (2009) , followed by over-night incubation with pri-288 mary and secondary antibodies as described above. If the phosphorylated epitope was 289 targeted during the first incubation, antibodies for the non-phosphorylated epitope was 290 used in the second and vice versa. Importantly, as this technique did not involve remov-291 ing the first primary antibody, antibodies from different hosts (mouse or rabbit) were used 292 for phosphorylated and non-phosphorylated epitopes respectively. HRP inactivation did 293 not affect the phosphospecific to non-phosphorylated signal ratios. For phospho-specific 294 S6K1, we used two antibodies. The first antibody produced bands corresponding to ∼ 295 80 kDa. This was slightly higher than expected (∼ 70 kDa), though within the range de-296 fined by the manufacturer. Therefore a second antibody was used validate the results. This antibody produced bands at a lower molecular weight (∼ 60 kDa), corresponding 298 to the predicted weight of the protein (UniProt identifier P23443-1). All incubation and 299 washing steps were performed at 4 ○ C using an automated membrane processor (Blot-300 Cycler, Precision Biosystems, Mansfield, MA, USA), except for S6K1-replication experi-301 ments, which was performed by hand in room temperature with incubations at 4 ○ C. For 302 each sample, total-protein and chemiluminescence quantification was calculated as the 303 mean value of two separate experiments. Total-protein content was quantified using Im- polyA External Standard Kit, Takara Bio Inc, Shiga, Japan) was added at a fixed amount (0.04 ng × ml −1 of Trizol reagent) per extraction prior to homogenization, as previously 324 described (Ellefsen et al., 2008 (Ellefsen et al., , 2014a . Following phase-separation, 400 µl of the upper 325 phase was transferred to a fresh tube and RNA was precipitated using isopropanol. The 326 resulting RNA pellet was washed three times with 70% EtOH and finally eluted in TE 327 buffer. RNA quantity and purity was evaluated using a spectrophotometer, all samples 328 had a 260/280 nm ratio > 1.95. RNA was stored at -80 ○ C until further processing. In the 329 analysis of total RNA content per-unit tissue weight, one sample was excluded prior to 330 analysis due to negative deviation from the expected value based on the relationship be-331 tween sample weight and RNA content suggesting sample loss in washing steps. RNA Training-effects on molecular characteristics (Total-RNA and western-blot data) were also 367 assessed using linear mixed-effects models specified with time and the time to exercise-368 volume interaction as fixed effects. Models were specified with random intercepts for 369 participants and when appropriate, random slopes for time and exercise-volume on the 370 level of participants. Model simplification was performed through reduction of random-371 effects parameters based on likelihood-ratio tests. Plots of residual and fitted values were 372 visually inspected to assess uniformity of variance over the fitted range. Whenever de-373 viations from these assumptions were identified, data were log-transformed and models 374 were re-fitted.
375
Generalized linear mixed-effects models (GLMM) were used to fit muscle fibre dis-additional benefit of multiple-sets. The measurement error was estimated from the base-transcripts at Week 2, particularly rRNA 18S (18S, 19.4 [0.8, 41 .4]%; 28S, 14.5 [-1.8, 33 .6]%; 483 5.8S 14.7 [-1.20, 33 .18]%). The abundances of these rRNA subspecies remained elevated 484 at week 12, though without clear differences between volume conditions ( Figure 4B ). The 485 rRNA precursor transcript 45S, measured per-unit total-RNA, did not increase from base-486 line to week 2, but increased by 48.8 [3.6, 113 .6]% in the single-sets condition at week 487 12, with multiple sets remaining near baseline levels (-28.8 [-50.4, 2 .1]% of single sets).
488
Overall, these data suggest that resistance training-induced increases in ribosomal con- 
493
Determinants of additional benefit of multiple-sets training 494 Fifteen participants showed a robust benefit of multiple-sets over single-sets for increases 495 in CSA, determined as differences in training-induced changes greater than the average 496 baseline between-leg variation in favour of multiple-sets (2.4% between leg variation at 497 baseline, Figure 5A ). To identify determinants of multiple-set benefits, we performed lo-498 gistic regression analyses with purposeful selection of variables. Variables initially se-499 lected for modelling are listed in Table 3 . After variable selection, total RNA content 500 per-unit tissue weight measured at rest in Week 2 remained as the single predictor (Table   501 4), with total RNA content being greater in the group having robust benefits of multiple 502 sets ( Figure 5C ). For every percentage-point increase in total-RNA in the multiple-sets 503 leg (compared to the single-set leg), the odds of multiple-sets benefit increased by 1.05 504 [1.00, 1.11] (Table 4 ). In all models, sex was included as a calibrating variable to account 505 for potential predictors with sex-dependent regulation (e.g. blood variables). However, 506 excluding sex and apparent sex-dependent variables from the variable selection, did not 507 affect the conclusion. As for muscle strength, 18 and 15 participants showed benefits of multiple sets for increases in 1RM knee-extension and leg-press (defined as a difference in 509 training-induced changes in favour of multiple-sets greater than the baseline between-leg 510 variation, 2.9 and 4.0% for the knee-extension and leg-press 1RM respectively). Variable 511 selection-analyses did not reveal significant determinants for this phenomenon.
512

Discussion
513
In the present study, multiple-set resistance training led to greater increases in muscle 514 strength and mass than single-set training. This is in agreement with results from meta- RNA. While most of these variables are already assumed to be volume sensitive, such 523 as muscle mass and strength (Krieger, 2009 (Krieger, , 2010 Schoenfeld et al., 2016) and mTOR-524 signaling (Burd et al., 2010; Terzis et al., 2010) , this is the first study to suggest that the IIX 525 → IIA fiber switch is also volume sensituive. Importantly, this adaptation is a hallmark 526 of resistance training adaptations (Andersen & Aagaard, 2000) . This study also suggests 527 that the volume-sensitive increase in ribosomal content is essential for beneficial effects 528 of increases in training volume on muscle growth, as shown by fifteen of the partici-529 pants. Arguably, the biological resolution of the present data was high due to the use of (Carpinelli & Otto, 1998; Krieger, 2010) .
539
In the present study, a large span of inter-individual variation in training responses 540 was evident for both gains in muscle strength and muscle mass. The observed varia-541 tion in muscle hypertrophy (SD of average %∆ CSA ∼ 4%) was comparable to that seen 542 in larger cohorts (Ahtiainen et al., 2016) . The strong correlation between responses to 543 the two volume-conditions (see Figure 6A ) further highlights the importance of within-544 participant analyses: if responses to one training protocol were strong, responses to the 545 other protocol were also strong. Consequently, our contralateral protocol resulted in 546 lower estimates of differences between volume-conditions on the population level, ex-547 pressed as relative gains in muscle mass per week, compared to a previous meta-analysis 548 (∼ 1.6 vs. ∼ 2.5% estimated from Table 3 in In our search for determinants that could explain the variation in muscle growth pat-559 terns to the two volume protocols, potential explanatory factors included baseline char-560 acteristics, blood variables, indices of mTOR-signaling and ribosome biogenesis as well as training charactersitics. Following variable selection, the only variable that could ex-562 plain additional benefits of multiple-over single-set training was levels of total RNA at 563 week 2 in the multiple-sets leg. As total RNA is a valid proxy marker of rRNA abundance 564 (Zak et al., 1967; Chaillou et al., 2014) , this suggests that early-phase, volume-dependent 565 ribosomal accumulation is a determinant of dose-response relationships between training 566 volume and muscle hypertrophy. In other words, the ability to induce superior increases 567 in ribosomal content in response to higher training volume is necessary to induce sub-568 sequent superiority in growth, probably acting by increasing protein synthesis capacity. relationship between RNA content and rate of protein synthesis (Millward et al., 1973) .
583
Variable selection did not identify other variables that could explain benefits of mod-584 erate training volume, discarding biological traits such as sex, baseline values of lean 585 mass and muscle fiber composition. Variable selection also discarded phosphorylation 586 of mTOR, along with phosphorylation of its downstream targets. This seems somewhat counterintuitive, as these signaling cues are regulators of ribosomal biogenesis and func-tion (Nader et al., 2005; Riggelen et al., 2010; West et al., 2016) , giving them potential roles 589 in accumulation of rRNA and total RNA and moderate-volume beneficence. However, 590 these signaling cues are acute-phase responders to resistance training that show phasic 591 and time-dependent regulation. This means that the measured change in for example 592 mTOR phosphorylation depends on factors such as timing of biopsy sampling, giving it 593 low resolution power and making it less suited for explanatory analyses. In accordance final model, the tendency towards a positive effect of higher IIX levels could be ascribed 616 to their greater growth potential (Stec et al., 2016; Jespersen et al., 2011) , with these fibres 617 having been in a state of disuse prior to the intervention. This implies a relatively rapid 618 transition of type IIX fibres into IIA fibres, which indeed was present in the data already 619 after two weeks of training at both protein and RNA levels. Correlation analyses revealed 620 that this transition was more pronounced in individuals with higher baseline levels of IIX, 621 with an r-value > 0.95 (data not shown), far exceeding the bias expected from regression-622 towards-the-mean.
623
To our knowledge, this is the first study to show that muscle fibre transitions from . * indicates that one session per week was performed at 90% of prescribed RM intensities. ↓ indicates muscle biopsy: Before (Week 0, n=34) and after the 12-wk intervention (Week 12, n=34), as well as before and after (1h) the fifth exercise session (Week 2 Pre-Ex and Post-Ex, n=33). ⊕ indicates strength test: before the intervention (Week 0, n=34) , after 5 and 9 weeks of training (n=18), and after finalization of the intervention (Week 12, n=34). Baseline strength was determined as the highest value obtained during two test sessions performed prior to the intervention. Body composition was measured prior to the intervention (Week 0) and after its finalization (Week 12, n=34) using full-body DXA and knee-extensor muscle MRI (.). a Descriptive statistics are grouped by sex; b , Sex was kept as a covariate in all models to account for sex-differences in independent variables; c , P-values are derived from likelihood-ratio tests; d testosterone measurements below detection limit coded as 0; e , baseline average of both legs. 
